Market Place
Sourcing Support
Novartis, AbbVie & PhRMA secure 340B court win in West Virginia
19 Dec 2024 //
ENDPTS
AbbVie buys Roche spinout Nimble Therapeutics for $200M
14 Dec 2024 //
PRESS RELEASE
AbbVie completes acquisition of Aliada Therapeutics
12 Dec 2024 //
INDPHARMAPOST
New combination treatments promising for blood cancers
11 Dec 2024 //
REUTERS
AbbVie Reports Emotional Impact Of CLL On Underrepresented Patients
10 Dec 2024 //
INDPHARMAPOST
Roche`s subQ Lunsumio matches IV version in lymphoma
10 Dec 2024 //
FIERCE PHARMA
AbbVie’s Parkinson’s drug succeeds in Phase 3 study
10 Dec 2024 //
PRESS RELEASE
AbbVie CLL survey shows emotional impact on patients of color
09 Dec 2024 //
FIERCE PHARMA
Epcoritamab Combo Shows High Response In Relapsed Follicular Lymphoma
07 Dec 2024 //
PR NEWSWIRE
AbbVie’s Skyrizi retains DTC spending crown
06 Dec 2024 //
FIERCE PHARMA
Alector’s AbbVie-Partnered Alzheimer’s Program Fails Ph 2
26 Nov 2024 //
BIOSPACE
AbbVie to Present at Citi`s 2024 Global Healthcare Conference
25 Nov 2024 //
PR NEWSWIRE
New IL-23 UC drugs `rapidly gained significant momentum`: report
18 Nov 2024 //
FIERCE PHARMA
AbbVie makes `Rheum for Dialogue` with new patient resource
18 Nov 2024 //
FIERCE PHARMA
AbbVie Receives EC Approval for ELAHERE® in Ovarian Cancer
18 Nov 2024 //
PR NEWSWIRE
AbbVie names first Migraine Career Catalyst Award winners
15 Nov 2024 //
FIERCE PHARMA
AbbVie Supports 20 Individuals with Migraine to Reach Career Goals
14 Nov 2024 //
PR NEWSWIRE
AbbVie’s $9B bet collapses as schizophrenia drug fails studies
12 Nov 2024 //
BIOPHARMADIVE
AbbVie & EvolveImmune Announce Cancer Biotherapeutics Collaboration
31 Oct 2024 //
GLOBENEWSWIRE
AbbVie`s Skyrizi overtakes Humira as top sales driver
31 Oct 2024 //
FIERCE PHARMA
AbbVie Reports Third-Quarter 2024 Financial Results
30 Oct 2024 //
PR NEWSWIRE
SkinSpirit join Allergan Aesthetics in Empowering New Gen. of Women
30 Oct 2024 //
PRESS RELEASE
SkinSpirit Joins Allergan In Supporting Girls Inc. STEM Initiative
29 Oct 2024 //
PR NEWSWIRE
AbbVie to buy Alzheimer`s therapy developer Aliada for $1.4 bln
29 Oct 2024 //
REUTERS
AbbVie makes Richter richer, paying $25M to form discovery pact
25 Oct 2024 //
FIERCE BIOTECH
AbbVie & Gedeon Announce Collaboration For Neuropsychiatric Targets
24 Oct 2024 //
PR NEWSWIRE
AbbVie`s Vyalev wins FDA nod in Parkinson`s after 2 rejections
18 Oct 2024 //
PRESS RELEASE
Allergan Aesthetics Presents Data At ASDS 2024 Conference
16 Oct 2024 //
PR NEWSWIRE
Lupin launches first generic of Pred Forte in the US
16 Oct 2024 //
EXPRESSPHARMA
Dupixent takes pharma DTC top spot in September
07 Oct 2024 //
FIERCE PHARMA
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
07 Oct 2024 //
FIERCE PHARMA
AbbVie cuts 2024 profit forecast citing R&D expenses
03 Oct 2024 //
REUTERS
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
EU withdraws marketing authorisation for Abbvie`s hepatitis C drug
02 Oct 2024 //
REUTERS
AbbVie to Host Third-Quarter 2024 Earnings Conference Call
01 Oct 2024 //
PR NEWSWIRE
AbbVie Submits BLA For Teliso-V In Non-Small Cell Lung Cancer
27 Sep 2024 //
PR NEWSWIRE
AbbVie Announces Topline Results from Ph 3 Trial of Tavapadon
27 Sep 2024 //
PR NEWSWIRE
AbbVie Announces Positive Tavapadon Phase 3 Results for PD
26 Sep 2024 //
PR NEWSWIRE
Docs discuss ongoing Humira use, name preferred biosimilars
24 Sep 2024 //
FIERCE PHARMA
Women Entrepreneurs: 2024 BOTOX® Grant Recipients Start Campaigns
24 Sep 2024 //
PR NEWSWIRE
AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine
21 Sep 2024 //
PR NEWSWIRE
New Migraine Drugs Less Effective Than Triptans
19 Sep 2024 //
FIERCE PHARMA
Ripple Therapeutics Collaborates AbbVie To Develop Next-Gen Glaucoma Therapies
17 Sep 2024 //
ACCESSWIRE
FDA Criticizes AbbVie For Misleading Claims In Serena Williams Ad
12 Sep 2024 //
FIERCE PHARMA
US FDA expands J&J`s psoriasis drug for inflammatory bowel disease
12 Sep 2024 //
REUTERS
AbbVie Sues BeiGene Over BTK Degrader Trade Secrets
11 Sep 2024 //
FIERCE BIOTECH
AbbVie`s Ubrelvy To Lead $16B+ Migraine Market By 2033 In Major Pharma Nations
11 Sep 2024 //
FIERCE PHARMA
UnitedHealth To Remove AbbVie`s Humira From Some US Reimbursement Lists
10 Sep 2024 //
REUTERS
AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets
10 Sep 2024 //
REUTERS
AbbVie Presents Solid Tumor Pipeline Data At ESMO 2024
09 Sep 2024 //
PR NEWSWIRE
AbbVie Declares Quarterly Dividend
06 Sep 2024 //
PR NEWSWIRE
Wet AMD Gene Therapy Could Reach Millions
03 Sep 2024 //
BIOSPACE
AbbVie`s Ubrelvy Effective Against Early Migraine Signs: Study
30 Aug 2024 //
FIERCE PHARMA
Express Scripts To Remove AbbVie`s Humira From Some 2025 Formularies
26 Aug 2024 //
FIERCE PHARMA
Bristol’ schizophrenia drug nears approval, AbbVie hope to provide competition
19 Aug 2024 //
BIOPHARMADIVE
Biden, Harris hail Medicare drug price cuts that will save billions
16 Aug 2024 //
REUTERS
Revance Agrees To $924M Buyout By Crown Laboratories
13 Aug 2024 //
FIERCE PHARMA
AbbVie’s Skyrizi, Rinvoq retake the top TV drug ad spenders’ crown
12 Aug 2024 //
FIERCE PHARMA
AbbVie`s Skyrizi And Rinvoq Top TV Drug Ad Spending
12 Aug 2024 //
FIERCE PHARMA
Allergan Aesthetics drives India’s potential in the global aesthetic market
11 Aug 2024 //
INDIANPHARMAPOST
